SCHEMBL7107797

SCHEMBL7107797

COc1[c]sc2cccc(-c3ccccn3)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.36
KDM4E B2RXH2 7/20 0.36
TP53 P04637 6/20 0.36
RAB9A P51151 6/20 0.36
NPC1 O15118 5/20 0.36
HSD17B10 Q99714 3/20 0.36
GAA P10253 2/20 0.36
PKM P14618 1/20 0.36
MAPT P10636 4/20 0.36
ALDH1A1 P00352 3/20 0.36
LMNA P02545 5/20 0.35
CCR1 P32246 2/20 0.35
CCR5 P51681 2/20 0.35
CCR8 P51685 2/20 0.35
POLB P06746 2/20 0.35
CYP1A2 P05177 1/20 0.35
METAP1 P53582 1/20 0.35
BLM P54132 1/20 0.35
HIF1A Q16665 1/20 0.35
DOHH Q9BU89 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7105859 0.84 CLK4 (0.35) ALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL7451102 0.84 ALDH1A1 (0.36) KDM4EHSD17B10GAAALDH1A1POLB
SCHEMBL7111089 0.72 SMN1; SMN2 (0.42) SMN1; SMN2KDM4ETP53RAB9ANPC1
SCHEMBL3525749 0.71 MEN1 (0.39) SMN1; SMN2KDM4ETP53HSD17B10GAA
SCHEMBL20172587 0.70 SMN1; SMN2 (0.52) SMN1; SMN2KDM4ETP53RAB9ANPC1
SCHEMBL1705582 0.68 KDM4E (0.40) SMN1; SMN2KDM4ETP53RAB9ANPC1
SCHEMBL7450197 0.67 KDM4E (0.42) SMN1; SMN2KDM4ETP53RAB9ANPC1
SCHEMBL7446349 0.67 KDM4E (0.42) SMN1; SMN2KDM4ETP53RAB9ANPC1
SCHEMBL483885 0.67 MIF (0.49) SMN1; SMN2KDM4ETP53RAB9ANPC1
SCHEMBL31614324 0.67 MIF (0.49) SMN1; SMN2KDM4ETP53RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030008901-A1 Hydroxy pipecolate hydroxamic acid derivatives MCCLURE KIM F (US) 2003-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030008901-A1 Hydroxy pipecolate hydroxamic acid derivatives MMP1, MMP10, MMP3 SMN1; SMN2 3318/4885KDM4E 3877/4885TP53 1171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.